| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,416 |
3,127 |
$689K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,822 |
5,593 |
$634K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,567 |
3,317 |
$551K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,537 |
1,463 |
$329K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,338 |
2,120 |
$176K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,632 |
1,550 |
$105K |
| V2784 |
Lens, polycarbonate or equal, any index, per lens |
2,121 |
1,046 |
$52K |
| V2020 |
Frames, purchases |
1,303 |
1,067 |
$51K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
650 |
354 |
$36K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,372 |
1,199 |
$30K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
852 |
742 |
$23K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
112 |
105 |
$18K |
| 36415 |
Collection of venous blood by venipuncture |
4,177 |
3,884 |
$16K |
| V2100 |
Sphere, single vision, plano to plus or minus 4.00, per lens |
1,027 |
463 |
$14K |
| 80053 |
Comprehensive metabolic panel |
1,967 |
1,893 |
$13K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,005 |
979 |
$10K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
113 |
104 |
$9K |
| 71046 |
Radiologic examination, chest; 2 views |
246 |
231 |
$8K |
| 87481 |
|
211 |
203 |
$8K |
| 80061 |
Lipid panel |
970 |
955 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,403 |
1,375 |
$7K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,619 |
1,423 |
$6K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
111 |
110 |
$6K |
| V2103 |
Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens |
190 |
152 |
$5K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
177 |
170 |
$4K |
| 87511 |
|
160 |
154 |
$3K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
54 |
47 |
$3K |
| 81513 |
|
38 |
38 |
$3K |
| V2101 |
Sphere, single vision, plus or minus 4.12 to plus or minus 7.00d, per lens |
191 |
104 |
$3K |
| 82607 |
|
270 |
265 |
$3K |
| 76830 |
Ultrasound, transvaginal |
46 |
42 |
$2K |
| 92134 |
|
191 |
179 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
91 |
72 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
399 |
389 |
$2K |
| 450 |
Pov group 1 hd 301-450 lbs |
18 |
15 |
$2K |
| 85027 |
|
431 |
414 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
63 |
61 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
47 |
43 |
$863.02 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
33 |
27 |
$840.49 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
54 |
47 |
$792.26 |
| 83540 |
|
154 |
152 |
$766.58 |
| 83550 |
|
137 |
135 |
$637.43 |
| 82728 |
|
71 |
70 |
$620.50 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
31 |
27 |
$525.52 |
| 83655 |
|
41 |
39 |
$336.14 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
14 |
14 |
$236.20 |
| 81001 |
|
86 |
50 |
$231.63 |
| 82570 |
|
57 |
56 |
$153.63 |
| 82043 |
|
46 |
46 |
$147.42 |
| 83605 |
|
42 |
41 |
$128.20 |
| 86803 |
|
12 |
12 |
$116.01 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
14 |
13 |
$48.38 |
| 84484 |
|
16 |
15 |
$45.65 |
| 83690 |
|
13 |
13 |
$23.13 |
| 85610 |
|
12 |
12 |
$23.10 |
| J7050 |
Infusion, normal saline solution, 250 cc |
587 |
392 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
417 |
372 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
22 |
19 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,130 |
1,975 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
403 |
365 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
851 |
812 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
29 |
23 |
$0.00 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
17 |
15 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
128 |
126 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
424 |
397 |
$0.00 |
| J0178 |
Injection, aflibercept, 1 mg |
27 |
25 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
70 |
65 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
41 |
34 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
17 |
13 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,473 |
1,311 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,263 |
1,177 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
79 |
75 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
103 |
95 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
93 |
90 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
192 |
136 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
16 |
15 |
$0.00 |
| J1756 |
Injection, iron sucrose, 1 mg |
26 |
12 |
$0.00 |